New Market Study Published: Febrile Neutropenia - Pipeline Review, H2 2012
Global Markets Direct's, 'Febrile Neutropenia - Pipeline Review, H2 2012', provides an overview of the Febrile Neutropenia therapeutic pipeline. This report provides information on the therapeutic development for Febrile Neutropenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Febrile Neutropenia. 'Febrile Neutropenia - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor...
View full press release